Instituut voor Neuropathische Pijn

NeurogesX, Inc. developed Qutenza, a dermal patch containing capsaicin, and proceeeds working in this field. They focus now on various other pain killers, and in the pipeline we find NGX-1998, a non-patch liquid formulation of capsaicin for neuropathic pain, NGX-1576, NGX-9674, and NGX-5752 prodrugs of acetaminophen for acute pain, NGX-6052, an opioid prodrug for chronic pain.

The company was previously known as Advanced Analgesics, Inc. and changed its name to NeurogesX, Inc. in September 2000.

NeurogesX, Inc. is headquartered in San Mateo, California.

March 2010, Jan M. Keppel Hesselink, MD, PhD